文献速递血栓与止血

重新思考凝血:从酶级联和细胞反应到涉及先天免疫激活的汇聚模型

Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation.
PubMed 文献 · Blood · 2023-01-01

综述回顾凝血模型从1960年代酶级联模型、千禧年前后细胞模型到当前免疫血栓形成概念的演变,指出先天免疫激活与适应性血凝块形成整合,并总结免疫、炎症与凝血交叉对话的主要分子。

要点

  • 凝血概念历经酶级联模型、细胞模型,现向整合先天免疫激活的汇聚模型演变。
  • 先天免疫激活是宿主损伤反应的一部分,与适应性血凝块形成整合而非分离。
  • COVID-19疫情中抗凝治疗反应不一和疫苗诱导免疫血栓性血小板减少症暴露了既有概念的局限。

核心结论

  • 先天免疫激活作为宿主损伤反应的一部分,与适应性血凝块形成整合,而非分离。
  • 将免疫、炎症与凝血的交叉对话叠加于级联和细胞模型,可演进对免疫止血生理学和免疫血栓形成病理学的概念理解。

研究设计与样本

  • 综述,总结当前对促进免疫、炎症与凝血交叉对话的主要分子的认识。

主要发现

  • 酶级联模型于1960年代首次描述,当时生物化学通过创新实验和技术发展而兴起。
  • 细胞模型将细胞协调整合到血凝块形成的酶学中,于千禧年之交细胞生物学成长期被概念化。
  • 每次进步都带来临床治疗学革命,包括促凝和抗凝治疗以改善患者护理。
  • COVID-19大流行中,包括抗凝治疗反应不一和疫苗诱导免疫血栓性血小板减少症在内的血栓挑战,暴露了既有概念的局限,同时要求新的治疗方法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Advancements in the conceptual thinking of hemostasis and thrombosis have been catalyzed by major developments within health research over several decades. The cascade model of coagulation was first described in the 1960s, when biochemistry gained prominence through innovative experimentation and technical developments. This was followed by the cell-based model, which integrated cellular coordination to the enzymology of clot formation and was conceptualized during the growth period in cell biology at the turn of the millennium. Each step forward has heralded a revolution in clinical therapeutics, both in procoagulant and anticoagulant treatments to improve patient care. In current times, the COVID-19 pandemic may also prove to be a catalyst: thrombotic challenges including the mixed responses to anticoagulant treatment and the vaccine-induced immune thrombotic thrombocytopenia have exposed limitations in our preexisting concepts while simultaneously demanding novel therapeutic approaches. It is increasingly clear that innate immune activation as part of the host response to injury is not separate but integrated into adaptive clot formation. Our review summarizes current understanding of the major molecules facilitating such a cross talk between immunity, inflammation and coagulation. We demonstrate how such effects can be layered upon the cascade and cell-based models to evolve conceptual understanding of the physiology of immunohemostasis and the pathology of immunothrombosis.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Yong J, Toh CH. Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation. Blood. 2023. PMID: 37890148. doi:10.1182/blood.2023021166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。